6 October 2025
Roche Launches AI-Based Kidney Disease Algorithm with CE Mark Approval
The AI-based tool aids early CKD risk assessment, integrating with existing systems to enhance patient care and reduce healthcare costs. Available in Europe, UK; US, Middle East, Asia to follow.
